Company profile
UK company 05395927, incorporated on 17 March 2005.
Boyds | Research and Drug Development Consultancy
A global drug development consultancy translating great science into medicinal products and treatments for the benefit of patients.
Company number 05395927
Updated 07 Jul 2026 09:49
Financial period: 1 Apr 2024 to 31 Mar 2025
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Jan 2017 to 31 Mar 2017
The effectiveness of cancer therapy can be limited by barriers to drug penetration at the tumour and the harbouring of drug-resistant cells in poorly oxygenated or "hypoxic" tumour regions - these becoming sources of spread. The UK company Oncotherics has developed non-toxic drugs that are designed to penetrate into these difficult to treat regions, sense...
